ACE2, angiotensin I converting enzyme 2, 59272

N. diseases: 253; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.050 Biomarker disease BEFREE Bioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure. 31833870 2019
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.050 GeneticVariation disease BEFREE Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues. 29490639 2018
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.050 GeneticVariation disease BEFREE Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. 29733687 2018
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.050 Biomarker disease BEFREE Patients with AHF had a higher serum ACE2 concentration than healthy volunteers (7.9 vs. 4.8 ng/mL, respectively; P = 0.002), but their serum Ang-(1-7) concentration was significantly lower (2.4 vs 3.1 ng/mL, respectively; P = 0.005). 27421979 2017
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.050 GeneticVariation disease BEFREE Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study. 29100503 2017